InvestorsHub Logo
Followers 50
Posts 943
Boards Moderated 0
Alias Born 05/06/2019

Re: None

Thursday, 07/01/2021 1:52:13 PM

Thursday, July 01, 2021 1:52:13 PM

Post# of 162770
On or before July 12th, we will be a company on the way to $20+ million in revenue.

Current 2021 Projected Revenue - $9 million
*Includes the added $100k per month starting in Q3 for PCR UTI & Wound in-house testing

In the pipeline....

Acquisition 1 - Mid-September to early October closing, but prefer to expedite.
Lab with $10 million in revenue - will result in annual revenue close to $20 million.

Acquisition 2 - June to early July closing - Lab with $1 million in revenue - will result in annual revenue close to $21 million.

*Estimates based on a full year of operations.



Grandeza Projected Revenue $1.5 million, and will grow just as fast as Helios.


People are still asking if this a good deal for RSHN shareholders?